Now’s the time to start consolidating and streamlining your routine molecular testing platforms and laboratory operations. Current market forces, including PAMA payment schedules and compliance requirements, are driving the need for these changes. At the same time, point-of-care molecular testing is a disruptive and relatively new model for providing urgent answers closer to the patient.
Regardless of whether or not your lab has begun this process, you will find this program highly beneficial for understanding how to lay the groundwork and garner stakeholder support for driving critical changes to improve testing models and empower your laboratory to sustainably meet the needs of your clinicians and patients.
Attendees will learn about:
- Market pressures in today’s healthcare environment that are making it essential for labs to evolve towards consolidated and less fragmented complex molecular testing models.
- How new molecular testing models are disrupting and replacing traditional models.
- Developing a strategy for building stakeholder support for prioritizing automation and consolidation.
View the full event program.
AACC designates this activity for a maximum of 1.5 ACCENT ® credit hours towards the AACC Clinical Chemist’s Recognition Award.